Beleggen.nl Markt MonitorMarkt Monitor

2012 financial statements and Investigations Brunel Americas completed (Koers spuit omhoog!)

1 Post
| Omlaag ↓
  1. forum rang 5 maci 15 mei 2013 16:48
    Brunel International NV: 2012 financial statements and Investigations Brunel Americas completed

    Press Release

    - 2012 financial statements
    - Investigations Brunel Americas completed

    Amsterdam, 15 May 2013


    2012 financial statements
    Brunel has published its 2012 financial statements. These are available on our website. The investigation in America has resulted in limited modifications to the results for 2012 as published on 1 March 2013. Adjusted to take account of the results of the investigation, and additional audit fees, the EBIT decreased by €1.8 million. The net result is virtually unchanged from the previously published figures, other than resulting from the restatement of the 2011 financial statements. The final results for 2012 are attached as an appendix to this press release.

    Brunel has amended the comparative figures in the 2012 financial statements to give a clear picture of the year-on-year development of activities and profitability. As a result of this restatement, EBIT for 2011 has been decreased by €3,5 million. The initially reported EBIT for 2012 has been increased by this amount. Further details on this restatement are included in our 2012 financial statements.

    Investigation into Brunel Americas
    Both our own additional internal investigations and the investigation by KPMG confirm our provisional findings: that the irregularities in the figures as reported by our office in Houston were an isolated incident and entirely attributable to a single employee.

    In 2012 we received some signals regarding the inadequate quality of the finance department in Houston. It appears that with the appointment of the regional financial controller of Brunel Americas in mid-2011, the necessary segregation of duties between accounting and control broke down, the impact of which was only spotted by Brunel in early 2013. Afterwards it was established that these errors had initially been the result of incompetence, and that in the course of 2012 there was some manipulation of internal reports and the disposition of €350.000.

    In the meantime, measures have been taken to prevent similar occurrences in the future. We are obviously very disappointed by the whole episode. On the other hand, we are relieved that the now completed investigations have indeed confirmed that the irregularities related exclusively to internally reported figures, and that no customers or contractors have been adversely affected in any way.

    Jan Arie van Barneveld: "We have carried out a root-and-branch investigation of the irregularities, and come to the conclusion that both their nature and scope are restricted to that which we initially uncovered a few months ago. And that is a huge relief. As a result of this occurrence, we are now more than ever aware of the importance of strong controls. This period has been an important lesson for us. Brunel will continue to evolve, as our growth and the quality of our controls must develop in parallel."
1 Post
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beleggen.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.072
AB InBev 2 5.521
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.741
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.753
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 191
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.754
Aedifica 3 918
Aegon 3.258 322.881
AFC Ajax 538 7.088
Affimed NV 2 6.297
ageas 5.844 109.895
Agfa-Gevaert 14 2.051
Ahold 3.538 74.341
Air France - KLM 1.025 35.082
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.042
Alfen 16 24.931
Allfunds Group 4 1.482
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.822
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.386
AMG 971 133.699
AMS 3 73
Amsterdam Commodities 305 6.697
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.017
Apollo Alternative Assets 1 17
Apple 5 383
Arcadis 252 8.785
Arcelor Mittal 2.034 320.770
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.326
Aroundtown SA 1 219
Arrowhead Research 5 9.745
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.268
ASML 1.766 108.099
ASR Nederland 21 4.502
ATAI Life Sciences 1 7
Atenor Group 1 509
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.687
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.404